《Neuro-oncology Advances》期刊

杂志介绍

JCR分区

中科院分区

3区

影响因子

4.6

CiteScore

5.9

期刊收录

SCIE

Neuro-oncology Advances（中文译名：《神经肿瘤学进展》），ISSN：2632-2498，是Oxford University Press出版的国际性学术期刊，2026年总发文量约211篇。该刊采用非OA开放访问，学科归属为Multiple。该刊是医学、肿瘤学领域的国际权威刊物，已被SCIE（科学引文索引扩展版）等国际主流学术数据库收录。2026年期刊影响因子达4.6，2025年期刊CiteScore为5.9，2025年期刊自引率约4.3%，在中科院期刊分区体系中位列医学大类3区，在所属学科领域具备高学术影响力与国际认可度。Neuro-oncology Advances长期聚焦医学、肿瘤学及相关产业的技术应用前沿，平均审稿周期12 Weeks，审稿流程高效稳定。在稿件录用评判中，该刊将创新性与前沿性作为核心遴选标准，重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

期刊评价

名词解释：

影响因子（Impact Factor, IF）：指该期刊前两年发表的文章，在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区：中科院分区表是国内主流的学术期刊分级评价工具，核心意义是建立跨学科可比的统一评价标尺，为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据，同时帮助科研人员筛选优质期刊、规避学术风险，适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》（2026年3月发布）

大类学科	小类学科	Top期刊	综述期刊
医学 3区	ONCOLOGY 肿瘤学 CLINICAL NEUROLOGY 临床神经病学 3区 3区	否	否

期刊分区表（2025年3月升级版）

大类学科	小类学科	Top期刊	综述期刊
医学 3区	CLINICAL NEUROLOGY 临床神经病学 ONCOLOGY 肿瘤学 3区 3区	否	否

JCR分区

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CLINICAL NEUROLOGY	ESCI	Q1	48 / 296	84
学科：ONCOLOGY	ESCI	Q2	101 / 333	69.8
学科：CLINICAL NEUROLOGY	ESCI	Q2	78 / 296	73.82
学科：ONCOLOGY	ESCI	Q2	88 / 333	73.72

2023-2024年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CLINICAL NEUROLOGY	ESCI	Q1	63 / 277	77.4
学科：ONCOLOGY	ESCI	Q2	104 / 322	67.9
学科：CLINICAL NEUROLOGY	ESCI	Q2	122 / 278	56.29
学科：ONCOLOGY	ESCI	Q2	128 / 322	60.4

中国学者近期发文

Pineal region germ cell tumors with secondary glioblastoma: A case report of long-term survival using chemoradiotherapy combined with TTField

Author:Li, Shaoqun; Lai, Mingyao; Chen, Lian; Zhou, Yingying; Li, Juan; Ye, Minting; Ai, Ruyu; Wang, LiChao; Zhang, Yangqiong; Cai, Linbo

Journal: NEURO-ONCOLOGY ADVANCES. 2026; Vol. 8, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf141

Tertiary lymphoid structures in glioblastoma: Association with multiparametric MRI imaging phenotypic features and patient surviva

Author:Zhou, Qing; Zhang, Peng; Xue, Caiqiang; Zhang, Bin; Ke, Xiaoai; Man, Jiangwei; Kang, Jia; Zhao, Zhiyong; Zhou, Junlin

Journal: NEURO-ONCOLOGY ADVANCES. 2026; Vol. 8, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf263

Emotional distress impairs immune checkpoint blockade efficacy in recurrent high-grade glioma: Insights from tumor in situ fluid analysi

Author:Wang, Dayang; Zhang, Jiubing; Liu, Guanzheng; Bu, Chaojie; Wei, Shaobin; Li, Minghao; Lv, Guangming; Sheng, Zhiyuan; Mei, Jie; Yan, Zhaoyue; Gao, Yushuai; Zhao, Ruijiao; Shi, Yujie; Wang, Meiyun; Bu, Xingyao

Journal: NEURO-ONCOLOGY ADVANCES. 2026; Vol. 8, Issue 1, pp. -. DOI: 10.1093/noajnl/vdag040

Integrated detection of cerebrospinal fluid cfDNA/cfRNA and molecular concordance with glioma characteristic

Author:Sun, Maoyuan; Jiang, Shan; Xu, Houshi; Zeng, Yulai; Liu, Beining; Wang, Yue; Li, Zhen; Guan, Yun; Chen, Jiawen; Zhu, Ruize; Ping, Weiqiu; Teng, Yanlin; Yan, Songlin; Liu, Liying; Shen, Dan; Tang, Qisheng; Fan, Zhen; Ng, Ho-Keung; Qin, Zhiyong; Mao, Ying; Shi, Zhifeng

Journal: NEURO-ONCOLOGY ADVANCES. 2026; Vol. 8, Issue 1, pp. -. DOI: 10.1093/noajnl/vdag039

Pre-treatment journey and outcome for children with intracranial non-germinomatous germ cell tumors-the Shanghai experienc

Author:Zhang, Anan; Huang, Xiang; Gao, Yijin; Chen, Haiyan; Qaddoumi, Ibrahim; Yang, Bo; Chen, Xiaolong; Liu, Anthony Pak-Yin; Zhang, Rong

Journal: NEURO-ONCOLOGY ADVANCES. 2026; Vol. 8, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf254

Impact of extent of surgical resection on survival in World Health Organization grade 4 gliomas: A molecular subtype-based analysi

Author:Hou, Ziming; Zhang, Wenhao; Yan, Zeya; Wang, Zihan; Hu, Jie; Liu, Xing; Fang, Shengyu; Jiang, Tao; Guo, Mian; Wang, Hao; Wang, Yinyan

Journal: NEURO-ONCOLOGY ADVANCES. 2026; Vol. 8, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf204

Multi-center real-world data-driven web calculator for predicting outcomes in IDH-mutant gliomas: Integrating molecular subtypes and treatment modalitie

Author:Xu, Houshi; Liu, Beining; Wang, Yue; Zhu, Ruize; Jiang, Shan; Soliman, Lina Akmal Fouad Abdelhamid; Chai, Huihui; Sun, Maoyuan; Chen, Jiawen; Li, Kay Ka-Wai; Ng, Ho-Keung; Zhang, Zhenyu; Wei, Junji; Shi, Zhifeng; Mao, Ying

Journal: NEURO-ONCOLOGY ADVANCES. 2025; Vol. 7, Issue 1, pp. -. DOI: 10.1093/noajnl/vdae221

MultiCubeNet: Multitask deep learning for molecular subtyping and prognostic prediction in glioma

Author:Zhang, Hongbo; Zhou, Beibei; Zhang, Hanwen; Zhang, Yuze; Ouyang, Ying; Su, Ruru; Tang, Xumei; Lei, Yi; Huang, Biao

Journal: NEURO-ONCOLOGY ADVANCES. 2025; Vol. 7, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf079

Deciphering the contributions of fecal microbiota from patients with high-grade glioma to tumor development in a humanized microbiome mouse model of gliom

Author:Wang, Cheng; Fan, Yiqi; Zhang, Lu; Zhao, Zhanyi; Luo, Feiyang; Sun, Kaijian; Zeng, Meiqin; Tian, Hao; Peng, Meichang; Luo, Yunhao; Zhao, Hailin; He, Shuai; Sun, Haitao

Journal: NEURO-ONCOLOGY ADVANCES. 2025; Vol. 7, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf085

Establishment and validation of a nomogram for predicting IDH-wildtype glioblastomas in nonenhancing adult-type diffuse glioma

Author:He, Lei; Fei, Fan; Zhou, Chengzhi; Bai, Xiaoyan; Yu, Shuqing; Wang, Lei; Xu, Ruxiang; Liu, Hanjie

Journal: NEURO-ONCOLOGY ADVANCES. 2025; Vol. 7, Issue 1, pp. -. DOI: 10.1093/noajnl/vdaf035